Clinical Trial Detail


Missing content? – Request curation!

Request curation for specific Genes, Variants, or PubMed publications.

Have questions, comments, or suggestions? - Let us know!

Email us at :

NCT ID NCT03634540
Title A Trial of PT2977 in Combination With Cabozantinib in Patients With Clear Cell Renal Cell Carcinoma (ccRCC)
Recruitment Active, not recruiting
Gender both
Phase Phase II
Variant Requirements No
Sponsors Peloton Therapeutics, Inc.
Age Groups: adult | senior
Covered Countries USA

Facility Status City State Zip Country Details
USC Norris Comprehensive Cancer Center ( Site 0060) Los Angeles California 90033 United States Details
Cedars Sinai Medical Center Samuel Oschin Comp. Cancer Institute ( Site 0003) Los Angeles California 90048 United States Details
Sylvester Comprehensive Cancer Center ( Site 0023) Miami Florida 33136 United States Details
Dana Farber Cancer Center ( Site 0006) Boston Massachusetts 02215 United States Details
Karmanos Cancer Institute ( Site 0033) Detroit Michigan 48201 United States Details
Tennessee Oncology, PLLC ( Site 0024) Chattanooga Tennessee 37404 United States Details
Tennessee Oncology, PLLC ( Site 0001) Nashville Tennessee 37203 United States Details
Texas Oncology-Baylor Charles A. Sammons Cancer Center ( Site 0010) Dallas Texas 75246 United States Details
Swedish Cancer Institute ( Site 0018) Seattle Washington 98104 United States Details
Seattle Cancer Care Alliance/Univ of Washington Medical Center ( Site 0035) Seattle Washington 98109 United States Details
*Shaded cells indicate that there was no data available from for the field